P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...
Related: Ulcerative Colitis vs. Crohn's Disease: What's the Difference? After going through the motions with numerous doctors ...
Medically reviewed by Kumkum Sarkar Patel, MD Crohn’s disease is an inflammatory bowel disease (IBD) that impacts your ...